Loading
Cancer survivors are a huge and growing population with specific long-term risks. Give each a plan matched to their risk, run automatically and shared with their family doctor.
Survivors face recurrence, second cancers, cardiovascular and endocrine late effects, and psychosocial and financial harm, but follow-up is either oncologist-heavy and unsustainable or absent. The proposal is a national survivorship model: an automated, treatment-specific survivorship care plan generated from the record at end of treatment, risk-stratified pathways (self-managed, primary care-led, shared care, specialist), scheduled surveillance triggered by the record, patient-reported outcome check-ins, and re-entry routes to oncology, with primary care paid for its role.
Shares Cardio-oncology, Supportive care and survivorship roadmap: making treatment bearable → proving it extends life → caring for tens of millions afterwards, Survivorship and late effects are neglected.
Shares Cardio-oncology, Supportive care and survivorship roadmap: making treatment bearable → proving it extends life → caring for tens of millions afterwards, Survivorship and late effects are neglected.
Shares The handover from children's to adult services, where follow-up falls away, Supportive care and survivorship roadmap: making treatment bearable → proving it extends life → caring for tens of millions afterwards, Fragmented care and guideline gaps, Survivorship and late effects are neglected.
Shares Treating fear of recurrence: the randomised trials, their effect sizes, and where the treatment is available, Fear that the cancer will come back: how common it is, and when it stops being ordinary worry, Survivorship and late effects are neglected.
Shares Cardio-oncology, Supportive care and survivorship roadmap: making treatment bearable → proving it extends life → caring for tens of millions afterwards, Survivorship and late effects are neglected.
Shares Post-traumatic stress after cancer: what is measured, and how much of it is measurement, Depression during and after cancer: the interview-based prevalence, and the care model that works, Fear that the cancer will come back: how common it is, and when it stops being ordinary worry, Survivorship and late effects are neglected.
Shares Cardio-oncology, Supportive care and survivorship roadmap: making treatment bearable → proving it extends life → caring for tens of millions afterwards, Survivorship and late effects are neglected.
Shares Treating fear of recurrence: the randomised trials, their effect sizes, and where the treatment is available, The handover from children's to adult services, where follow-up falls away, Survivorship and late effects are neglected.